Aquatic Capital Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
VPM
VCM
S
Aquatic Capital Management's NVAX Position: Q1 2026 in Review
Aquatic Capital Management reduced its Novavax (NVAX) stake by 44% in Q1 2026, selling an estimated $392K and leaving 55,138 shares worth $449K. The position accounts for 0.01% of the portfolio, ranked #786.
Aquatic Capital Management first reported a position in NVAX in Q2 2022 and has held it in 3 quarters since. The position peaked at $661K in Q4 2025. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Aquatic Capital Management held 55,138 shares of Novavax worth $449K as of Q1 2026.
- Aquatic Capital Management sold 43,211 Novavax shares in Q1 2026, an estimated $392K.
- Novavax made up 0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #786 holding.
- Aquatic Capital Management first reported a position in Novavax in Q2 2022 and has held it in 3 quarters since.
- Aquatic Capital Management's Novavax position peaked at $661K in Q4 2025.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.